Venus Concept Inc.VEROEarnings & Financial Report
Venus Concept Inc is a global medical technology firm specializing in the development, manufacturing, and distribution of non-invasive and minimally invasive aesthetic medical devices. Its product portfolio covers hair removal, skin rejuvenation, body contouring, and anti-aging solutions, serving dermatology clinics, plastic surgery centers, and medical spas across North America, Europe, and Asia Pacific markets.
VERO Q3 FY2025 Key Financial Metrics
Revenue
$13.8M
Gross Profit
$8.8M
Operating Profit
$-9.5M
Net Profit
$-22.6M
Gross Margin
64.0%
Operating Margin
-68.9%
Net Margin
-163.8%
YoY Growth
-8.2%
EPS
$-12.14
Venus Concept Inc. Q3 FY2025 Financial Summary
Venus Concept Inc. reported revenue of $13.8M (down 8.2% YoY) for Q3 FY2025, with a net profit of $-22.6M (down 143.0% YoY) (-163.8% margin). Cost of goods sold was $5.0M, operating expenses totaled $18.3M.
Key Financial Metrics
| Total Revenue | $13.8M |
|---|---|
| Net Profit | $-22.6M |
| Gross Margin | 64.0% |
| Operating Margin | -68.9% |
| Report Period | Q3 FY2025 |
Revenue Breakdown
Venus Concept Inc. Q3 FY2025 revenue of $13.8M breaks down across 2 segments, led by Products And Services at $10.8M (78.7% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Products And Services | $10.8M | 78.7% |
| Leases | $2.9M | 21.3% |
Venus Concept Inc. Revenue by Segment — Quarterly Trend
Venus Concept Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Products And Services and Leases) has evolved quarter over quarter.
| Segment | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 |
|---|---|---|---|---|
| Products And Services | $10.8M | $11.0M | $11.0M | $13.2M |
| Leases | $2.9M | $4.7M | $2.6M | — |
Venus Concept Inc. Annual Revenue by Year
Venus Concept Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $64.8M).
Venus Concept Inc. Quarterly Revenue & Net Profit History
Venus Concept Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 FY2025 | $13.8M | -8.2% | $-22.6M | -163.8% |
| Q2 FY2025 | $15.7M | -5.4% | $-11.7M | -74.7% |
| Q1 FY2025 | $13.6M | -21.9% | $-12.4M | -90.6% |
| Q4 FY2024 | $15.8M | -13.1% | $-8.0M | -50.5% |
| Q3 FY2024 | $15.0M | -14.8% | $-9.3M | -61.9% |
| Q2 FY2024 | $16.6M | -17.4% | $-20.0M | -120.3% |
| Q1 FY2024 | $17.5M | -14.9% | $-9.8M | -56.0% |
| Q4 FY2023 | $18.1M | -25.3% | $-11.1M | -61.3% |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.1M | $17.5M | $16.6M | $15.0M | $15.8M | $13.6M | $15.7M | $13.8M |
| YoY Growth | -25.3% | -14.9% | -17.4% | -14.8% | -13.1% | -21.9% | -5.4% | -8.2% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $93.7M | $85.1M | $79.8M | $72.3M | $68.2M | $63.5M | $63.1M | $61.6M |
| Liabilities | $107.1M | $107.0M | $75.4M | $61.6M | $65.3M | $60.7M | $60.3M | $58.5M |
| Equity | $-14.0M | $-22.5M | $3.7M | $10.1M | $2.4M | $2.3M | $2.3M | $2.7M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-774000 | $-2.9M | $-1.3M | $-3.0M | $-3.8M | $-6.3M | $-5.4M | $-4.9M |